Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

NBIXNBIX
18 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in NEUROCRINE BIOSCIENCES INC

No. Point72 Asset Management exited its NBIX (Neurocrine Biosciences) position in Q2 2024. Its Q1 2024 13F listed 837,426 shares worth $115.5M. Point72 Asset Management first reported NBIX in Q1 2019 and held it in 14 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$34.2M

Total Shares Change

-388,692

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%$137.67
0
2024-Q1
Decreased
837,426
-39.8%
$115.5M0.3%$137.92
0
2023-Q4
Decreased
1.4M
-46.0%
$183.4M0.4%$131.76
0
2023-Q3
Increased
2.6M
+2215.2%
$290M0.8%$112.50
70
2023-Q2
New
111,358
-
$10.5M0.0%$94.30
38
2022-Q3
Exited
0
-100.0%
$00.0%$106.21
0
2022-Q2
Increased
665,300
+15.1%
$64.9M0.3%$97.48
41
2022-Q1
Increased
577,898
+9.5%
$54.2M0.2%$93.75
39
2021-Q4
Increased
527,774
+254.3%
$45M0.2%$85.17
56
2021-Q3
New
148,948
-
$14.3M0.1%$95.91
39
2021-Q1
Exited
0
-100.0%
$00.0%$97.25
0
2020-Q4
New
22,679
-
$2.2M0.0%$95.85
36
2020-Q2
Exited
0
-100.0%
$00.0%$122.00
0
2020-Q1
Decreased
18,124
-69.8%
$1.6M0.0%$86.55
0
2019-Q4
Increased
60,003
+103.1%
$6.5M0.0%$107.49
44
2019-Q3
Decreased
29,544
-97.4%
$2.7M0.0%$90.11
0
2019-Q2
Increased
1.1M
+189.3%
$95M0.5%$84.43
58
2019-Q1
New
388,692
-
$34.2M0.2%$88.10
48

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used